盐酸氨溴索雾化吸入治疗婴幼儿支气管肺炎的临床疗效观察

目的观察盐酸氨溴索雾化吸入治疗婴幼儿支气管肺炎的临床疗效。方法选择2006年7月-2008年7月收治的128例婴幼儿支气管肺炎患儿，随机分为对照组和治疗组，每纽各64例。在常规抗感染及对症治疗的基础上，对照组采用糜蛋白酶雾化吸入治疗，治疗组采用盐酸氨溴索雾化吸入治疗。结果治疗组的显效率、总有效率均明显高于对照组，两组比较差异有统计学意义（P〈0．05）。治疗组在咳嗽消失、体温恢复正常、气促消失及肺部哆音消失方面均短于对照组，两组比较差异有统计学意义（P〈0．05）。结论盐酸氨溴索雾化吸入治疗婴幼儿支气管肺炎疗效可靠．安全性高．依从性高．值得临床推广。

Observation of Clinical Effect of Ambroxol Hydrocholride Nebulization in Treatment with Infant Bronchopneumonia

OBJECTIVE To observe the clinical effect of ambroxol hydrochloride nebulization in treatment with infant bronchopneumonia METHODS From July 2006 to July 2008, the 128 cases of infant bronchopneumonia were randomly separated into control group （64 cases）and the treatment group （64 cases）. Tow groups giving anti infection, symptomatic and supportive treatment conventionally altogether, and the treatment group accepted ambroxol hyrochloride nebulization, while the infants in control group were received chymotrypsin nebulization. RESULTS The excellence rates and total effective rates in treatment group were significantly higher than those in control group （P〈0.05）. The disappearing time of cough, wheezy sound in lung and admission duration in treatment group ＇were shorter than in control group（P〈0.05）. CONCLUSION Ambroxol hydrochloride nebulization is reliable and safe in treatment with infant bronchopneumonia and is worth applying clinic.